Unknown

Dataset Information

0

Hepatic Manifestations of Cystic Fibrosis.


ABSTRACT: Cystic fibrosis liver disease (CFLD) remains the third leading cause of death in patients with cystic fibrosis. Although most patients with CFLD present in childhood, recent studies suggest a second wave of liver disease in adulthood. There are no clear guidelines for diagnosing CFLD. Treatment options for CFLD remain limited, and while UDCA is widely used, its long-term benefit is unclear. Those who develop hepatic decompensation or uncontrolled variceal bleeding may benefit from liver transplant, either alone, or in combination with lung transplant.

SUBMITTER: Sakiani S 

PROVIDER: S-EPMC6452885 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hepatic Manifestations of Cystic Fibrosis.

Sakiani Sasan S   Kleiner David E DE   Heller Theo T   Koh Christopher C  

Clinics in liver disease 20190221 2


Cystic fibrosis liver disease (CFLD) remains the third leading cause of death in patients with cystic fibrosis. Although most patients with CFLD present in childhood, recent studies suggest a second wave of liver disease in adulthood. There are no clear guidelines for diagnosing CFLD. Treatment options for CFLD remain limited, and while UDCA is widely used, its long-term benefit is unclear. Those who develop hepatic decompensation or uncontrolled variceal bleeding may benefit from liver transpla  ...[more]

Similar Datasets

| S-EPMC6830504 | biostudies-literature
| S-EPMC4051580 | biostudies-literature
| 2726863 | ecrin-mdr-crc
| S-EPMC5996105 | biostudies-literature
| S-EPMC7041544 | biostudies-literature
2005-03-10 | GSE2395 | GEO
| S-EPMC7191434 | biostudies-literature
| S-EPMC5036583 | biostudies-literature
2011-01-07 | E-GEOD-26482 | biostudies-arrayexpress
| S-EPMC5547424 | biostudies-other